Epigenetic perspectives on cancer chemotherapy response

Mou-Ze Liu1, Howard L McLeod, Fa-Zhong He

  • 1Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha, Hunan, 410078, PR China.

Pharmacogenomics
|May 7, 2014
PubMed

Insights

Epigenetic modifications influence cancer drug response by affecting drug metabolism and cancer progression. Understanding these epigenetic changes is key for developing effective anticancer therapies and improving drug efficacy.

Area of Science:

  • Oncology
  • Epigenetics
  • Pharmacology

Background:

  • Epigenetic programs play a crucial role in cancer development.
  • The influence of epigenetics on anticancer drug response remains incompletely understood.
  • Epigenetic drugs are a rapidly developing area in cancer treatment.

Purpose of the Study:

  • To elucidate how epigenetic modifications impact anticancer drug responses.
  • To review major epigenetic regulatory mechanisms and their role in cancer.
  • To promote rational clinical use of anticancer drugs and guide epigenetic drug development.

Main Methods:

  • Review of major epigenetic regulatory mechanisms: DNA methylation, miRNA regulation, and histone modification.
  • Analysis of epigenetic involvement in genes controlling drug absorption, distribution, metabolism, and excretion (ADME).
  • Examination of epigenetic regulation in cancer pathological progression.

Main Results:

  • Epigenetic modifications regulate genes involved in drug ADME, thus affecting drug bioavailability and efficacy.
  • Epigenetic changes contribute to cancer progression, influencing overall response to therapy.
  • Major epigenetic mechanisms (DNA methylation, miRNA, histone modification) are implicated in drug response.

Conclusions:

  • Epigenetic modifications significantly influence anticancer drug responses through various mechanisms.
  • A deeper understanding of epigenetics is essential for optimizing cancer treatment strategies.
  • Targeting epigenetic regulation holds promise for novel anticancer drug development and personalized medicine.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K